Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Konakion MM Paediatric 2mg/0.2ml inj ampoules (Cheplapharm)
0906060Q0BBAGAS
|
Konakion | Phytomenadione | Nutrition and Blood | 149 |
|
Konakion MM 10mg/1ml solution for injection ampoules
0906060Q0BBAFAB
|
Konakion | Phytomenadione | Nutrition and Blood | 25 |
|
Konakion 10mg tablets
0906060Q0BBAAAC
|
Konakion | Phytomenadione | Nutrition and Blood | 1 |
|
Konakion MM Paediatric 2mg/0.2ml inj amps (Imported(France))
0906060Q0BBAHAS
|
Konakion | Phytomenadione | Nutrition and Blood | 1 |
|
Konakion Neonatal 1mg/0.5ml solution for injection ampoules
0906060Q0BBADAA
|
Konakion | Phytomenadione | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.